Chungyong Han
Overview
Explore the profile of Chungyong Han including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Choi B, Kim S, Kim Y, Lee D, Oh H, Han C, et al.
Eur J Immunol
. 2018 Aug;
48(10):1739-1749.
PMID: 30138536
RELT (tumor necrosis factor receptor superfamily member 19-like, TNFRSF19L) is a TNFR superfamily member that is primarily expressed in immune cells and lymphoid tissues, but whose immunological function is not...
12.
Han C, Sim S, Kim S, Singh R, Hwang S, Kim Y, et al.
Nat Commun
. 2018 Feb;
9(1):468.
PMID: 29391449
Chimeric antigen receptor (CAR) T cell therapy is an effective method for treating specific cancers. CARs are normally designed to recognize antigens, which are highly expressed on malignant cells but...
13.
Han C, Kwon B
Immunotherapy
. 2018 Jan;
10(3):221-234.
PMID: 29370727
Chimeric antigen receptor (CAR) T cells have outstanding therapeutic potential for treating blood cancers. The prospects for this technology have accelerated basic research, clinical translation and Big Pharma's investment in...
14.
Kim K, Choi B, Kim Y, Han C, Oh H, Lee D, et al.
Autophagy
. 2016 Jul;
12(9):1647-59.
PMID: 27440002
VSIG4/CRIg (V-set and immunoglobulin domain containing 4) is a transmembrane receptor of the immunoglobulin superfamily that is expressed specifically on macrophages and mature dendritic cells. VSIG4 signaling accelerates phagocytosis of...
15.
Choi B, Lee D, Lee D, Kim Y, Kim S, Oh H, et al.
Cell Mol Immunol
. 2016 Mar;
14(9):748-757.
PMID: 26972770
4-1BB (CD137) is a strong enhancer of the proliferation of CD8 T cells. Since these cells require increased production of energy and biomass to support their proliferation, we hypothesized that...
16.
Katoh J, Kawana-Tachikawa A, Shimizu A, Zhu D, Han C, Nakamura H, et al.
PLoS One
. 2016 Mar;
11(3):e0150397.
PMID: 26953793
HIV-1 escape from CTL is predictable based on the Human Leukocyte Antigen (HLA) class I alleles expressed by the host. As such, HIV-1 sequences circulating in a population of hosts...
17.
Han C, Kawana-Tachikawa A, Shimizu A, Zhu D, Nakamura H, Adachi E, et al.
Retrovirology
. 2014 Jun;
11:38.
PMID: 24886641
Background: Human Leukocyte Antigen (HLA) class I restricted Cytotoxic T Lymphocytes (CTLs) exert substantial evolutionary pressure on HIV-1, as evidenced by the reproducible selection of HLA-restricted immune escape mutations in...
18.
Shimizu A, Kawana-Tachikawa A, Yamagata A, Han C, Zhu D, Sato Y, et al.
Sci Rep
. 2013 Nov;
3:3097.
PMID: 24192765
We investigated the crystal structure of an HLA-A*2402-restricted CTL epitope in the HIV-1 nef gene (Nef134-10) before (pHLA) or after TCR docking. The wild type epitope and two escape mutants...
19.
Han C, Ihara M, Ueda H
J Biosci Bioeng
. 2013 Feb;
116(1):17-21.
PMID: 23415663
In this report, we describe a novel method for directly preparing enzyme-labeled antibodies harvested from IgM-producing hybridoma cells. We constructed expression vectors for antibody light (L) chain-enzyme fusion proteins by...